quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication

Digestion

Volumn 69, Issue 1, 2004, Pages 27-33

  Van Grieken, Nicole C T ^a   Meijer, Gerrit A ^a   Kale, Ilse ^a   Bloemena, Elisabeth ^a   Lindeman, Jan ^b   Offerhaus, G Johan A ^c   Meuwissen, Stefan G M ^a   Baak, Jan P A ^e   Kuipers, Ernst J ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e SIR Hospital   (Norway)

Author keywords

Antrum; Eradication therapy, Helicobacter pylori; Follow up, gastric antrum atrophy; Gastric atrophy; Helicobacter pylori; Point counting; Stereology

Indexed keywords

OMEPRAZOLE;

ACCURACY; ARTICLE; ATROPHY; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; ERADICATION THERAPY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; STEREOMETRY; STOMACH ANTRUM;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ATROPHY; BIOPSY; ENDOSCOPY, GASTROINTESTINAL; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PYLORIC ANTRUM; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1542618314     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076544     Document Type: Article

References (16)

1. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process. Cancer Res 1992;52:6735-6740.
2. Cheli R, Giacosa A: Chronic atrophic gastritis and gastric mucosal atrophy - one and the same. J Clin Pathol 1983;29:23-25.
3. Correa P: Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 1988;83:504-509.
4. Stolte M, Heilmann KL: Neue Klassifikation and Graduierung der Gastritis. Leber Magen Darm 1989;90:220-226.
5. Price AB: The Sydney System: Histological division. J Gastroenterol Hepatol 1991;6:209-222.
6. Dixon MF, Genta RM, Yardley JH, et al: Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
7. El-Zimaity HM, Graham DY, Al-Assi MT, et al: Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
8. Andrew A, Wyatt JI, Dixon MF: Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25:317-322.
9. Guarner J, Herrera-Goepfert R, Mohar A, et al: Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol 1999;30:1431-1434.
10. Offerhaus GJ, Price AB, Haot J, et al: Observer agreement on the grading of gastric atrophy. Histopathology 1999;34:320-325.
11. van Grieken NC, Weiss MM, Meijer GA, et al: Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001;54:63-69.
12. Schenk BE, Kuipers EJ, Nelis GF, et al: Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 2000;46:615-621.
13. van Grieken NC, Meijer GA, Weiss MM, et al: Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: A randomized follow-up study. Am J Gastroenterol 2001;96:2882-2886.
14. You WC, Li JY, Blot WJ, et al: Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-619.
15. Sipponen P, Kekki M, Haapakoski J, et al: Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-177.
16. Dixon MF: Prospects for intervention in gastric carcinogenesis: Reversibility of gastric atrophy and intestinal metaplasia. Gut 2001;49:2-4.